FDA Approves Treosulfan Regimen For Preparative Use in Stem Cell Transplantation Patients With AML, MDS
The FDA approved treosulfan (Grafapex; Medexus Pharma) in combination with fludarabine (Fludara; Bayer HealthCare Pharmaceuticals) as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in adult and pediatric patients 1 …